書誌情報
O-187. SUNFISH試験 : 脊髄性筋萎縮症 (SMA) II型及び歩行不能III型患者におけるリスジプラム (RG7916) の有効性及び安全性
齋藤加代子1, Mercuri Eugenio2, Barisic Nina3, Kostera-Pruszczyk Anna4, Masson Riccardo5, Mazzone Elena2, Nascimento Andres6, Vuillerot Carole7, Fuerst-Recktenwald Sabine8, Gerber Marianne8, Gorni Ksenija8, Kletzl Heidemarie8, Yin Yeung Wai9, Day John W10
1東京女子医科大学臨床ゲノムセンター, 2Paediatric Neurology and Nemo Center, Catholic University and Policlinico Gemelli, 3Clinical Medical Center Zagreb, University of Zagreb Medical School, Department of Paediatrics, 4Katedra I Klinika Neurologii Warszawskiego Uniwersytetu, 5Carlo Besta Neurological Research Institute Foundation, Developmental Neurology Unit, 6Neuromuscular UnLit, Neuropaediatrics Department, Hospital Sant Joan de Deu, Fundacion Sant Joan de Deu, CIBERER-ISC III., 7Department of Pediatric Physical Medicine and Rehabilitation, Hopital Mere Enfant, CHU-Lyon, 8F.Hoffmann-La Roche Ltd., 9Roche Products Ltd., 10Department of Neurology. Stanford University
脳と発達 52(suppl): S283-S283, 2020.
個人会員・法人会員の方（IDが5または10で始まる方）
- 全文ダウンロード： 従量制、基本料金制の方共に121円(税込) です。
